Literature DB >> 1407516

MRI and SPECT findings in amyotrophic lateral sclerosis. Demonstration of upper motor neurone involvement by clinical neuroimaging.

F Udaka1, H Sawada, N Seriu, K Shindou, N Nishitani, M Kameyama.   

Abstract

MRI was performed in 21 patients and single photon emission computed tomography (SPECT) with N-isopropyl-p-123I iodoamphetamine in 16 patients, to visualize upper motor neurone lesions in amyotrophic lateral sclerosis. T2-weighted MRI revealed high signal along the course of the pyramidal tract in the internal capsule and cerebral peduncle in 4 of 21 patients. SPECT images were normal in 4 patients, but uptake was reduced in the cerebral cortex that includes the motor area in 11.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1407516     DOI: 10.1007/bf00596496

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  13 in total

1.  The representation of the pyramidal tract in the internal capsule and basis pedunculi. A study based on three cases of amyotrophic lateral sclerosis.

Authors:  K HIRAYAMA; T TSUBAKI; Y TOYOKURA; S OKINAKA
Journal:  Neurology       Date:  1962-05       Impact factor: 9.910

2.  Amyotrophic lateral sclerosis.

Authors:  T LAWYER; M G NETSKY
Journal:  AMA Arch Neurol Psychiatry       Date:  1953-02

3.  Amyotrophic lateral sclerosis.

Authors:  A P FRIEDMAN; D FREEDMAN
Journal:  J Nerv Ment Dis       Date:  1950-01       Impact factor: 2.254

4.  Focal signal-intensity variations in the posterior internal capsule: normal MR findings and distinction from pathologic findings.

Authors:  S Mirowitz; K Sartor; M Gado; R Torack
Journal:  Radiology       Date:  1989-08       Impact factor: 11.105

5.  [Neuropathological study of 61 cases of amyotrophic lateral sclerosis. Nosological discussion].

Authors:  P Castaigne; F Lhermitte; J Cambier; R Escourolle; P Le Bigot
Journal:  Rev Neurol (Paris)       Date:  1972-10       Impact factor: 2.607

6.  The central nervous system in motor neurone disease.

Authors:  B Brownell; D R Oppenheimer; J T Hughes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-06       Impact factor: 10.154

Review 7.  Presenile dementia combined with amyotrophy: a review of 34 Japanese cases.

Authors:  K Morita; H Kaiya; T Ikeda; M Namba
Journal:  Arch Gerontol Geriatr       Date:  1987-09       Impact factor: 3.250

8.  Localization of the pyramidal tract in the internal capsule by whole brain dissection.

Authors:  E D Ross
Journal:  Neurology       Date:  1980-01       Impact factor: 9.910

9.  Cortical motor-sensory hypometabolism in amyotrophic lateral sclerosis: a PET study.

Authors:  J Hatazawa; R A Brooks; M C Dalakas; L Mansi; G Di Chiro
Journal:  J Comput Assist Tomogr       Date:  1988 Jul-Aug       Impact factor: 1.826

10.  Lowered cerebral glucose utilization in amyotrophic lateral sclerosis.

Authors:  M C Dalakas; J Hatazawa; R A Brooks; G Di Chiro
Journal:  Ann Neurol       Date:  1987-11       Impact factor: 10.422

View more
  5 in total

Review 1.  Neuroimaging in amyotrophic lateral sclerosis.

Authors:  Sumei Wang; Elias R Melhem; Harish Poptani; John H Woo
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Magnetic resonance signal abnormalities along the pyramidal tracts in amyotrophic lateral sclerosis.

Authors:  F Carella; M Grisoli; M Savoiardo; D Testa
Journal:  Ital J Neurol Sci       Date:  1995-11

3.  Involvement of corpus callosum in amyotrophic lateral sclerosis shown by MRI.

Authors:  M Van Zandijcke; J Casselman
Journal:  Neuroradiology       Date:  1995-05       Impact factor: 2.804

4.  Combined 3T diffusion tensor tractography and 1H-MR spectroscopy in motor neuron disease.

Authors:  M Nelles; W Block; F Träber; U Wüllner; H H Schild; H Urbach
Journal:  AJNR Am J Neuroradiol       Date:  2008-08-13       Impact factor: 3.825

Review 5.  Transcranial magnetic stimulation and amyotrophic lateral sclerosis: pathophysiological insights.

Authors:  Steve Vucic; Ulf Ziemann; Andrew Eisen; Mark Hallett; Matthew C Kiernan
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-12-21       Impact factor: 10.154

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.